Jenaro Astray-Mochales1, Ana López de Andres2, Valentín Hernandez-Barrera3, Cristina Rodríguez-Rieiro4, Pilar Carrasco Garrido5, María D Esteban-Vasallo6, Maria Felicitas Domínguez-Berjón7, Isabel Jimenez-Trujillo8, Rodrigo Jiménez-García9. 1. Department of Epidemiology, Directorate of Health Promotion and Prevention, Ministry of Health, Community of Madrid, C/ Julián Camarillo, 4B, 28037 Madrid, Spain. Electronic address: jenaro.astray@salud.madrid.org. 2. Preventive Medicine and Public Health Department, Rey Juan Carlos University, Avda de Atenas s/n, Alcorcón, 28922 Madrid, Spain. Electronic address: ana.lopez@urjc.es. 3. Preventive Medicine and Public Health Department, Rey Juan Carlos University, Avda de Atenas s/n, Alcorcón, 28922 Madrid, Spain. Electronic address: valentin.hernandez@urjc.es. 4. Preventive Medicine and Public Health Department, Rey Juan Carlos University, Avda de Atenas s/n, Alcorcón, 28922 Madrid, Spain. Electronic address: rodriguezrieiro@gmail.com. 5. Preventive Medicine and Public Health Department, Rey Juan Carlos University, Avda de Atenas s/n, Alcorcón, 28922 Madrid, Spain. Electronic address: pilar.carrasco@urjc.es. 6. Department of Epidemiology, Directorate of Health Promotion and Prevention, Ministry of Health, Community of Madrid, C/ Julián Camarillo, 4B, 28037 Madrid, Spain. Electronic address: maria.estebanv@salud.madrid.org. 7. Department of Epidemiology, Directorate of Health Promotion and Prevention, Ministry of Health, Community of Madrid, C/ Julián Camarillo, 4B, 28037 Madrid, Spain. Electronic address: felicitas.dominguez@salud.madrid.org. 8. Preventive Medicine and Public Health Department, Rey Juan Carlos University, Avda de Atenas s/n, Alcorcón, 28922 Madrid, Spain. Electronic address: Isabel.jimenez@urjc.es. 9. Preventive Medicine and Public Health Department, Rey Juan Carlos University, Avda de Atenas s/n, Alcorcón, 28922 Madrid, Spain. Electronic address: rodrigo.jimenez@urjc.es.
Abstract
OBJECTIVES: We aim to describe influenza vaccination coverage for the Spanish population using data from two consecutive nation-wide representative health surveys. The data was analysed by high risk groups, health care workers (HCWs) and immigrants. Also, coverage trends were analysed. MATERIAL AND METHODS: The 2011/12 Spanish National Health Survey (N=21,007) and the 2014 European Health Interview Survey for Spain (N=22,842) were analysed. Influenza vaccination status was self-reported. Time trends for were estimated by a multivariate logistic regression model. RESULTS: Overall vaccination uptake was similar in 2011/12 and 2014, 19.1% and 18.9%, respectively, (p>0.05). 47% of the subjects surveyed were in the groups for which vaccination was recommended with coverages of 41.1% in 2011/12 and 40% in 2014 (p>0.05). In both surveys, uptake among subjects with a chronic disease was three times higher than uptake in subjects who did not have these diseases. In 2011/12 and 2014, 20% and 27.6% of health workers were vaccinated. Subjects born outside Spain were vaccinated less frequently than Spanish-born subjects (9.3% vs 20.4% and 8.9% vs 20%). Within the diseases studied, the best uptake was for patients with heart disease (52.5% in 2011/12 and 51.1% in 2014) and patients with diabetes (50.5% and 51.8%). Multivariate analysis showed that older age, having a chronic disease or being a HCW increases the possibility of being vaccinated whereas being born outside Spain decreased it. CONCLUSIONS: Seasonal influenza vaccine uptake rates in the recommended target groups, patients with chronic conditions and health care workers, in Spain are unacceptably low and seem to be stable in the post pandemic seasons. This finding should alert health authorities to the need to work directly with health care providers on the indications for this vaccine and to study strategies that make it possible to increase vaccination uptake.
OBJECTIVES: We aim to describe influenza vaccination coverage for the Spanish population using data from two consecutive nation-wide representative health surveys. The data was analysed by high risk groups, health care workers (HCWs) and immigrants. Also, coverage trends were analysed. MATERIAL AND METHODS: The 2011/12 Spanish National Health Survey (N=21,007) and the 2014 European Health Interview Survey for Spain (N=22,842) were analysed. Influenza vaccination status was self-reported. Time trends for were estimated by a multivariate logistic regression model. RESULTS: Overall vaccination uptake was similar in 2011/12 and 2014, 19.1% and 18.9%, respectively, (p>0.05). 47% of the subjects surveyed were in the groups for which vaccination was recommended with coverages of 41.1% in 2011/12 and 40% in 2014 (p>0.05). In both surveys, uptake among subjects with a chronic disease was three times higher than uptake in subjects who did not have these diseases. In 2011/12 and 2014, 20% and 27.6% of health workers were vaccinated. Subjects born outside Spain were vaccinated less frequently than Spanish-born subjects (9.3% vs 20.4% and 8.9% vs 20%). Within the diseases studied, the best uptake was for patients with heart disease (52.5% in 2011/12 and 51.1% in 2014) and patients with diabetes (50.5% and 51.8%). Multivariate analysis showed that older age, having a chronic disease or being a HCW increases the possibility of being vaccinated whereas being born outside Spain decreased it. CONCLUSIONS: Seasonal influenza vaccine uptake rates in the recommended target groups, patients with chronic conditions and health care workers, in Spain are unacceptably low and seem to be stable in the post pandemic seasons. This finding should alert health authorities to the need to work directly with health care providers on the indications for this vaccine and to study strategies that make it possible to increase vaccination uptake.
Authors: Aleksandra Pettke; Sophie Jocham; Andreas Wiener; Andreas Löcken; Judith Groenefeld; Martina Ahlmann; Andreas H Groll Journal: Support Care Cancer Date: 2017-07-21 Impact factor: 3.603
Authors: Miguel Saro-Buendía; Ángel Marrero-Sánchez; Daniel García-Ruiz de Morales; Guillermo Chiara-Graciani; Jaime Coderch-Carretero; María Asunción Pérez-Jacoiste Asín; José Tiago Silva; Mario Fernández-Ruiz; Pilar Arrazola; José María Aguado; Francisco López-Medrano Journal: Hum Vaccin Immunother Date: 2021-06-15 Impact factor: 4.526
Authors: Jose J Zamorano-Leon; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Javier de-Miguel-Diez; David Carabantes-Alarcon; Romana Albaladejo-Vicente; Rosa Villanueva-Orbaiz; Khaoula Zekri-Nechar; Sara Sanz-Rojo Journal: J Clin Med Date: 2021-12-23 Impact factor: 4.241
Authors: Marta Fuentes-Alonso; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Jose J Zamorano-Leon; David Carabantes-Alarcon; Isabel Jimenez-Trujillo; Sara Sanz-Rojo; Javier de Miguel-Diez Journal: J Clin Med Date: 2022-03-04 Impact factor: 4.964
Authors: Camino Prada-García; Virginia Fernández-Espinilla; Cristina Hernán-García; Iván Sanz-Muñoz; José Martínez-Olmos; Jose M Eiros; Javier Castrodeza-Sanz Journal: Int J Environ Res Public Health Date: 2022-09-05 Impact factor: 4.614